latest news releases from the newsroom
XOMA to Present At Susquehanna Financial Group Healthcare Conference On March 4
BERKELEY, Calif., Feb. 27, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference. The presentation will take place in New York on Tuesday, March 4, 2008 at 3:00 p.m. Eastern time.
Power Medical Interventions, Inc.
Power Medical Interventions, Inc. Reports 2007 Financial Results
LANGHORNE, Pa., Feb. 27, 2008 (PRIME NEWSWIRE) -- Power Medical Interventions(r), Inc. (Nasdaq:PMII), a leader in developing and commercializing Intelligent Surgical Instruments(tm), today announced financial results for the fourth quarter and twelve months ended December 31, 2007.
Athersys Announces Summary Results for Phase 1 Safety Study of Its Novel Obesity Drug
CLEVELAND, Feb. 27, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced top-line results from its Phase 1 clinical trial of ATHX-105, its orally administered drug candidate for the treatment of obesity. ATHX-105 was well-absorbed, providing good drug exposures, well-tolerated up to high doses, and had no negative effect on cardiovascular, hematology or other clinical parameters.
Achillion Pharmaceuticals, Inc.
Achillion Reports 2007 Fourth Quarter and Year-End Financial Results
NEW HAVEN, Conn., Feb. 27, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the quarter and year ended December 31, 2007.
Universal Detection Technology
Universal Detection Technology Inks Contract to Bring EPA Approved Anti-MRSA Products to Market
LOS ANGELES, Feb. 27, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UDTT) (Frankfurt:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has inked a deal to market a line of Anti-Microbial Products approved by the Environmental Protection Agency (EPA). The Product is designed to kill 99.9% of bacteria including Methicillin-resistant Staphylococcus (MRSA), E.coli, Norovirus, and Salmonella.
NASDAQ Announces Mid-month Open Short Interest Positions in NASDAQ Stocks as of Settlement Date February 15, 2008
NEW YORK, Feb. 27, 2008 (PRIME NEWSWIRE) -- At the end of the settlement date of February 15, 2008, short interest in 2,698 NASDAQ Global Market(sm) securities totaled 8,865,941,056 shares compared with 8,441,146,548 shares in 2,707 Global Market issues reported for the prior settlement date of January 31, 2008. The mid-February short interest represents 3.51 days average daily NASDAQ Global Market share volume for the reporting period, compared with 2.94 days for the prior reporting period.
SoundBite Communications, Inc.
SoundBite Communications Acquires Mobile Collect
BEDFORD, Mass., Feb. 27, 2008 (PRIME NEWSWIRE) -- SoundBite Communications, Inc. (Nasdaq:SDBT), a leading provider of on-demand customer contact solutions, announced that it has acquired essentially all of the assets of Mobile Collect, Inc. in an all-cash transaction of approximately $500,000 plus additional contingent consideration of up to $2 million based upon a certain percent of text messaging revenue. This additional consideration will be earned and paid in future periods. Mobile Collect is a Software as a Service (SaaS) provider of mobile communications solutions and a pioneer in Free-to-End User (FTEU) text messaging. The acquisition accelerates SoundBite's vision of delivering a hosted, multi-channel communications platform to its clients.
SoundBite Communications, Inc.
SoundBite Communications Reports Fourth Quarter and Full Year 2007 Financial Results
BEDFORD, Mass., Feb. 27, 2008 (PRIME NEWSWIRE) -- SoundBite Communications, Inc. (Nasdaq:SDBT), a leading provider of on-demand automated voice messaging solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2007. Fourth quarter revenues were $11.3 million, an increase of 24.3% from the same quarter in 2006.
Medicis Pharmaceutical Corporation
Medicis Reports Fourth Quarter and Year End 2007 Financial Results
SCOTTSDALE, Ariz., Feb. 27, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues for the three months ended December 31, 2007 of approximately $140.3 million, compared to approximately $99.1 million for the three months ended December 31, 2006, representing an increase of approximately 42%. This increase was primarily due to strength in prescriptions of our core acne products, which include SOLODYN(R), TRIAZ(R) and ZIANA(R). Medicis' net income in accordance with U.S. generally accepted accounting principles ("GAAP") for the three months ended December 31, 2007 was approximately $27.5 million, or approximately $0.41 per diluted share, compared to net income in accordance with GAAP of $17.9 million, or approximately $0.27 per share, for the three months ended December 31, 2006. Non-GAAP net income for the three months ended December 31, 2007 was approximately $36.8 million, or approximately $0.54 per diluted share, compared to GAAP and non-GAAP net income of $17.9 million, or $0.27 per diluted share, for the three months ended December 31, 2006. There were no non-GAAP adjustments for the three months ended December 31, 2006.